DBV Technologies | Aktywa



Assets Zmiana Data
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amarin USD 750.62M 49.24M 2024-09
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
DBV Technologies USD 65.7M 27.36M 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12



DBV Technologies Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.